B-cell epitopes in GroEL of Francisella tularensis

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Lu, Zhaohua ^a   Rynkiewicz, Michael J ^a   Madico, Guillermo ^a   Li, Sheng ^b   Yang, Chiou Ying ^a,c   Perkins, Hillary M ^a   Sompuram, Seshi R ^d   Kodela, Vani ^d   Liu, Tong ^b   Morris, Timothy ^b   Wang, Daphne ^b   Roche, Marly I ^a,e   Seaton, Barbara A ^a   Sharon, Jacqueline ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d Medical Discovery Partners LLC   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONIN 60; EPITOPE; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY; BACTERIAL PROTEIN; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CROSS REACTION; CRYSTAL STRUCTURE; DEUTERIUM HYDROGEN EXCHANGE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FRANCISELLA TULARENSIS; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; TH1 CELL; TULAREMIA; WESTERN BLOTTING; X RAY CRYSTALLOGRAPHY; ANIMAL; ANTIBODY COMBINING SITE; B LYMPHOCYTE; CHEMISTRY; CLASSIFICATION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; POINT MUTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BACTERIAL PROTEINS; BINDING SITES, ANTIBODY; CHAPERONIN 60; EPITOPES; FRANCISELLA TULARENSIS; MICE; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN BINDING; TULAREMIA;

EID: 84903388337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099847     Document Type: Article

References (113)

1. McLendon MK, Apicella MA, Allen LA (2006) Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol 60: 167-185. (Pubitemid 44627945)
2. Sjostedt A (2007) Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 1105: 1-29.
3. Thomas LD, Schaffner W (2010) Tularemia pneumonia. Infect Dis Clin North Am 24: 43-55.
4. Tarnvik A, Chu MC (2007) New approaches to diagnosis and therapy of tularemia. Ann N Y Acad Sci 1105: 378-404. (Pubitemid 47507098)
5. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, et al. (2001) Tularemia as a biological weapon: medical and public health management. Jama 285: 2763-2773. (Pubitemid 32525374)
6. Conlan JW (2011) Tularemia vaccines: recent developments and remaining hurdles. Future Microbiol 6: 391-405.
7. Oyston PC (2009) Francisella tularensis vaccines. Vaccine 27 Suppl 4: D48-51.
8. Elkins KL, Cowley SC, Bosio CM (2007) Innate and adaptive immunity to Francisella. Ann N Y Acad Sci 1105: 284-324. (Pubitemid 47507095)
9. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D, Winegar RK (1996) Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun 64: 3288-3293. (Pubitemid 26256178)
10. Wu TH, Hutt JA, Garrison KA, Berliba LS, Zhou Y, et al. (2005) Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 73: 2644-2654. (Pubitemid 40570329)
11. Leiby DA, Fortier AH, Crawford RM, Schreiber RD, Nacy CA (1992) In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun 60: 84-89.
12. Stenmark S, Sunnemark D, Bucht A, Sjostedt A (1999) Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect Immun 67: 1789-1797. (Pubitemid 29144398)
13. Elkins KL, Bosio CM, Rhinehart-Jones TR (1999) Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect Immun 67: 6002-6007. (Pubitemid 29508130)
14. Drabick JJ, Narayanan RB, Williams JC, Leduc JW, Nacy CA (1994) Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am J Med Sci 308: 83-87. (Pubitemid 24309308)
15. Fortier AH, Slayter MV, Ziemba R, Meltzer MS, Nacy CA (1991) Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun 59: 2922-2928.
16. Foshay L (1940) Tularemia: A summary of certain aspects of disease including methods for early diagnosis and the results of serum treatment in 600 patients. Medicine 19: 1-83.
17. Fulop M, Mastroeni P, Green M, Titball RW (2001) Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19: 4465-4472. (Pubitemid 32718670)
18. Kirimanjeswara GS, Golden JM, Bakshi CS, Metzger DW (2007) Prophylactic and Therapeutic Use of Antibodies for Protection against Respiratory Infection with Francisella tularensis. J Immunol 179: 532-539. (Pubitemid 46986570)
19. Kirimanjeswara GS, Olmos S, Bakshi CS, Metzger DW (2008) Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis. Immunol Rev 225: 244-255.
20. Klimpel GR, Eaves-Pyles T, Moen ST, Taormina J, Peterson JW, et al. (2008) Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine 26: 6874-6882.
21. Rhinehart-Jones TR, Fortier AH, Elkins KL (1994) Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells. Infect Immun 62: 3129-3137. (Pubitemid 24232092)
22. Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, et al. (2007) A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 75: 2591-2602. (Pubitemid 46744351)
23. Stenmark S, Lindgren H, Tarnvik A, Sjostedt A (2003) Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. Microb Pathog 35: 73-80. (Pubitemid 36952285)
24. Apicella MA, Post DM, Fowler AC, Jones BD, Rasmussen JA, et al. (2010) Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One 5: e11060.
25. Wang Q, Shi X, Leymarie N, Madico G, Sharon J, et al. (2011) A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides. Biochemistry 50: 10941-10950.
26. Conlan JW, Shen H, Webb A, Perry MB (2002) Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20: 3465-3471. (Pubitemid 35248070)
27. Fulop M, Manchee R, Titball R (1995) Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia. Vaccine 13: 1220-1225.
28. Fulop M, Manchee R, Titball R (1996) Role of two outer membrane antigens in the induction of protective immunity against Francisella tularensis strains of different virulence. FEMS Immunol Med Microbiol 13: 245-247. (Pubitemid 26133338)
29. Khlebnikov VS, Vetchinin SS, Grechko GK, Averina AA, Golovlev IR, et al. (1992) [The preventive activity of monoclonal antibodies specific to the lipopolysaccharide of Francisella tularensis]. Zh Mikrobiol Epidemiol Immunobiol: 67-70.
30. Li J, Ryder C, Mandal M, Ahmed F, Azadi P, et al. (2007) Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Microbiology 153: 3141-3153. (Pubitemid 47517074)
31. Lu Z, Madico G, Roche MI, Wang Q, Hui JH, et al. (2012) Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia. Immunology 136: 352-360.
32. Lu Z, Roche MI, Hui JH, Unal B, Felgner PL, et al. (2007) Generation and characterization of hybridoma antibodies for immunotherapy of tularemia. Immunol Lett 112: 92-103. (Pubitemid 47379853)
33. Savitt AG, Mena-Taboada P, Monsalve G, Benach JL (2009) Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy. Clin Vaccine Immunol 16: 414-422.
34. Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, et al. (2009) Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. Vaccine 27: 597-605.
35. Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW (2011) Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Vaccine 29: 6941-6947.
36. Horwich AL, Apetri AC, Fenton WA (2009) The GroEL/GroES cis cavity as a passive anti-aggregation device. FEBS Lett 583: 2654-2662.
37. Ranson NA, White HE, Saibil HR (1998) Chaperonins. Biochem J 333 (Pt 2): 233-242. (Pubitemid 28379521)
38. Ericsson M, Tarnvik A, Kuoppa K, Sandstrom G, Sjostedt A (1994) Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect Immun 62: 178-183. (Pubitemid 24011957)
39. Fink AL (1999) Chaperone-mediated protein folding. Physiol Rev 79: 425-449.
40. Maguire M, Coates AR, Henderson B (2002) Chaperonin 60 unfolds its secrets of cellular communication. Cell Stress Chaperones 7: 317-329. (Pubitemid 36008744)
41. Wick G (2000) Atherosclerosis-an autoimmune disease due to an immune reaction against heat-shock protein 60. Herz 25: 87-90.
42. Xu Z, Horwich AL, Sigler PB (1997) The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature 388: 741-750. (Pubitemid 27375147)
43. Chen DH, Madan D, Weaver J, Lin Z, Schroder GF, et al. (2013) Visualizing GroEL/ES in the act of encapsulating a folding protein. Cell 153: 1354-1365.
44. Grason JP, Gresham JS, Lorimer GH (2008) Setting the chaperonin timer: a two-stroke, two-speed, protein machine. Proc Natl Acad Sci U S A 105: 17339-17344.
45. Rye HS, Roseman AM, Chen S, Furtak K, Fenton WA, et al. (1999) GroEL-GroES cycling: ATP and nonnative polypeptide direct alternation of folding-active rings. Cell 97: 325-338. (Pubitemid 29214589)
46. Pfister G, Stroh CM, Perschinka H, Kind M, Knoflach M, et al. (2005) Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci 118: 1587-1594. (Pubitemid 40691887)
47. Henderson B (2010) Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem Funct 28: 1-14.
48. Hoffman PS, Garduno RA (1999) Surface-associated heat shock proteins of Legionella pneumophila and Helicobacter pylori: roles in pathogenesis and immunity. Infect Dis Obstet Gynecol 7: 58-63. (Pubitemid 29215672)
49. Lee BY, Horwitz MA, Clemens DL (2006) Identification, recombinant expression, immunolocalization in macrophages, and T-cell responsiveness of the major extracellular proteins of Francisella tularensis. Infect Immun 74: 4002-4013. (Pubitemid 43993332)
50. Melillo A, Sledjeski DD, Lipski S, Wooten RM, Basrur V, et al. (2006) Identification of a Francisella tularensis LVS outer membrane protein that confers adherence to A549 human lung cells. FEMS Microbiol Lett 263: 102-108. (Pubitemid 44357708)
51. Janovska S, Pavkova I, Hubalek M, Lenco J, Macela A, et al. (2007) Identification of immunoreactive antigens in membrane proteins enriched fraction from Francisella tularensis LVS. Immunol Lett 108: 151-159. (Pubitemid 46198959)
52. Habich C, Burkart V (2007) Heat shock protein 60: regulatory role on innate immune cells. Cell Mol Life Sci 64: 742-751. (Pubitemid 46474983)
53. Quintana FJ, Cohen IR (2011) The HSP60 immune system network. Trends Immunol 32: 89-95.
54. Eyles JE, Unal B, Hartley MG, Newstead SL, Flick-Smith H, et al. (2007) Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics 7: 2172-2183. (Pubitemid 47067203)
55. Bae JE, Schurig GG, Toth TE (2002) Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens. Vet Microbiol 88: 189-202. (Pubitemid 34804790)
56. Bansal A, Paliwal PK, Sagi SS, Sairam M (2010) Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection. Mol Cell Biochem 337: 213-221.
57. Hechard C, Grepinet O, Rodolakis A (2004) Molecular cloning of the Chlamydophila abortus groEL gene and evaluation of its protective efficacy in a murine model by genetic vaccination. J Med Microbiol 53: 861-868. (Pubitemid 39238391)
58. Leclerq S, Harms JS, Rosinha GM, Azevedo V, Oliveira SC (2002) Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene. J Med Microbiol 51: 20-26. (Pubitemid 34060129)
59. Lin J, Adams LG, Ficht TA (1996) Immunological response to the Brucella abortus GroEL homolog. Infect Immun 64: 4396-4400. (Pubitemid 26318174)
60. Noll A, Roggenkamp A, Heesemann J, Autenrieth IB (1994) Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis. Infect Immun 62: 2784-2791. (Pubitemid 24203961)
61. Vanniasinkam T, Barton MD, Heuzenroeder MW (2004) The immunogenicity of Rhodococcus equi GroEL2-based vaccines in a murine model. Vet Immunol Immunopathol 98: 91-100. (Pubitemid 38209994)
62. Yamaguchi H, Osaki T, Kai M, Taguchi H, Kamiya S (2000) Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun 68: 3448-3454. (Pubitemid 30340443)
63. Noll A, AutenriethIB (1996) Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect Immun 64: 2955-2961. (Pubitemid 26256132)
64. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, et al. (1991) Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 59: 665-670.
65. van der Zee R, Anderton SM, Prakken AB, Liesbeth Paul AG, van Eden W (1998) T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity. Semin Immunol 10: 35-41. (Pubitemid 28108129)
66. Takahashi I, Nakagawa I, Xu L, Hamada S (1996) Role of alpha beta T cells and gamma delta T cells in protective immunity to Actinobacillus actinomycetemcomitans in mutant mice by targeted gene disruption. J Periodontal Res 31: 589-595. (Pubitemid 126463421)
67. Linhares IM, Witkin SS (2010) Immunopathogenic consequences of Chlamydia trachomatis 60 kDa heat shock protein expression in the female reproductive tract. Cell Stress Chaperones 15: 467-473.
68. Wendling U, Farine JC (1998) Oral administration of HSP-containing E. coli extract OM-89 has suppressive effects in autoimmunity. Regulation of autoimmune processes by modulating peripheral immunity towards hsp's? Biotherapy 10: 223-227.
69. Prakken B, Wauben M, van Kooten P, Anderton S, van der Zee R, et al. (1998) Nasal administration of arthritis-related T cell epitopes of heat shock protein 60 as a promising way for immunotherapy in chronic arthritis. Biotherapy 10: 205-211. (Pubitemid 28156643)
70. van Eden W, Wendling U, Paul L, Prakken B, van Kooten P, et al. (2000) Arthritis protective regulatory potential of self-heat shock protein cross-reactive T cells. Cell Stress Chaperones 5: 452-457. (Pubitemid 32057497)
71. Noah CE, Malik M, Bublitz DC, Camenares D, Sellati TJ, et al. (2010) GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages. Infect Immun 78: 1797-1806.
72. Havlasova J, Hernychova L, Brychta M, Hubalek M, Lenco J, et al. (2005) Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 5: 2090-2103. (Pubitemid 40770573)
73. Twine SM, Petit MD, Fulton KM, House RV, Conlan JW (2010) Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS). PLoS One 5: e10000.
74. Twine SM, Petit MD, Shen H, Mykytczuk NC, Kelly JF, et al. (2006) Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines. Biochem Biophys Res Commun 346: 999-1008.
75. Ericsson M, Kroca M, Johansson T, Sjostedt A, Tarnvik A (2001) Long-lasting recall response of CD4+ and CD8+ alphabeta T cells, but not gammadelta T cells, to heat shock proteins of francisella tularensis. Scand J Infect Dis 33: 145-152. (Pubitemid 32178002)
76. Valentino MD, Maben ZJ, Hensley LL, Woolard MD, Kawula TH, et al. (2011) Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets. Immunology 132: 348-360.
77. Hartley MG, Green M, Choules G, Rogers D, Rees DG, et al. (2004) Protection afforded by heat shock protein 60 from Francisella tularensis is due to copurified lipopolysaccharide. Infect Immun 72: 4109-4113. (Pubitemid 38821926)
78. Murphy K (2011) Janeway's Immunobiology. New York: Garland Science. 888 p. p.
79. Eyles JE, Hartley MG, Laws TR, Oyston PC, Griffin KF, et al. (2008) Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS). Microb Pathog 44: 164-168. (Pubitemid 350297674)
80. Kulis M, Gorentla B, Burks AW, Zhong XP (2013) Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. Mol Nutr Food Res 57: 906-915.
81. Polewicz M, Gracia A, Garlapati S, van Kessel J, Strom S, et al. (2013) Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine 31: 3148-3155.
82. Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, et al. (2008) An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Vaccine 26: 5276-5288.
83. Larsson P, Oyston PC, Chain P, Chu MC, Duffield M, et al. (2005) The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet 37: 153-159.
84. Woods VL Jr, Hamuro Y (2001) High resolution, high-throughput amide deuterium exchange-mass spectrometry (DXMS) determination of protein binding site structure and dynamics: utility in pharmaceutical design. J Cell Biochem Suppl Suppl 37: 89-98.
85. Zhang Z, Smith DL (1993) Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci 2: 522-531. (Pubitemid 23119303)
86. Sharon J, Rynkiewicz MJ, Lu Z, Yang CY (2014) Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics. Immunology 142(1): 1-23.
87. Haste Andersen P, Nielsen M, Lund O (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15: 2558-2567. (Pubitemid 44771693)
88. Madej T, Addess KJ, Fong JH, Geer LY, Geer RC, et al. (2012) MMDB: 3D structures and macromolecular interactions. Nucleic Acids Res 40: D461-464.
89. Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40: 717-721. (Pubitemid 10174894)
90. Schlimok G, Gottlinger H, Funke I, Swierkot S, Hauser H, et al. (1986) In vivo and in vitro labelling of epithelial tumor cells with anti 17-1A monoclonal antibodies in bone marrow of cancer patients. Hybridoma 5 Suppl 1: S163-170. (Pubitemid 16072930)
91. Roche MI, Lu Z, Hui JH, Sharon J (2011) Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide. Hybridoma (Larchmt) 30: 19-28.
92. Shulman M, Wilde CD, Kohler G (1978) A better cell line for making hybridomas secreting specific antibodies. Nature 276: 269-270. (Pubitemid 9053903)
93. Rynkiewicz MJ, Lu Z, Hui JH, Sharon J, Seaton BA (2012) Structural Analysis of a Protective Epitope of the Francisella tularensis O-Polysaccharide. Biochemistry 51: 5684-5694.
94. Sharon J, Sompuram SR, Yang CY, Williams BR, Sarantopoulos S (2002) Construction of polyclonal antibody libraries using phage display. Methods Mol Biol 178: 101-112.
95. Madico G, Quinn TC, Rompalo A, McKee KT Jr, Gaydos CA (1998) Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 36: 3205-3210. (Pubitemid 28476166)
96. Madico G, Quinn TC, Boman J, Gaydos CA (2000) Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol 38: 1085-1093. (Pubitemid 30140565)
97. Klimpel GR, Eaves-Pyles T, Moen ST, Taormina J, Peterson JW, et al. (2008) Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody. Vaccine.
98. Kiefer F, Arnold K, Künzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL Repository and associated resources. Nucleic Acids Research 37: D387-D392.
99. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics 22: 195-201. (Pubitemid 43205406)
100. Peitsch MC (1995) Protein modeling by E-mail. Bio/Technology 13: 658-660.
101. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 18: 2714-2723. (Pubitemid 28059943)
102. Marcatili P, Rosi A, Tramontano A (2008) PIGS: automatic prediction of antibody structures. Bioinformatics 24: 1953-1954.
103. Aiyegbo MS, Eli IM, Spiller BW, Williams DR, Kim R, et al. (2013) Differential accessibility of a rotavirus VP6 epitope in trimers comprising type I, II, or III channels as revealed by binding of a human rotavirus VP6-specific antibody. J Virol 88: 469-476.
104. Otwinowski Z, Minor W (1997) Methods Enzymol 276: 307-326.
105. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
106. Barbas CF 3rd, Heine A, Zhong G, Hoffmann T, Gramatikova S, et al. (1997) Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science 278: 2085-2092. (Pubitemid 28028312)
107. Serriere J, Dugua JM, Bossus M, Verrier B, Haser R, et al. (2011) Fab′-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography. J Mol Biol 405: 33-42.
108. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132. (Pubitemid 41742764)
109. Comeau SR, Gatchell DW, Vajda S, Camacho CJ (2004) ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 20: 45-50. (Pubitemid 38088339)
110. Comeau SR, Gatchell DW, Vajda S, Camacho CJ (2004) ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 32: W96-99. (Pubitemid 38997307)
111. Comeau SR, Kozakov D, Brenke R, Shen Y, Beglov D, et al. (2007) ClusPro: performance in CAPRI rounds 6-11 and the new server. Proteins 69: 781-785. (Pubitemid 350210138)
112. Kozakov D, Brenke R, Comeau SR, Vajda S (2006) PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 65: 392-406. (Pubitemid 44454112)
113. Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774-797. (Pubitemid 47321791)